Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Orthofix MedicalFRA:OM2 +1.75%60 Days Payable is 87.95 as of Jun. 2026, which is 21% above its 10-year median of 72.52. GuruFocus rates FRA:OM2 with a GF Score™ of 60/100 and a GF Value™ of €12.11 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 793 Medical Devices & Instruments companies, Orthofix Medical ranks better than 58.01% on this metric.
The historical rank and industry rank for Orthofix Medical's Days Payable or its related term are showing as below:
FRA:OM2'
s Days Payable Range Over the Past 10 Years
Min: 60.25 Med: 72.52 Max: 83.11
Current: 83.11
During the past 13 years, Orthofix Medical's highest Days Payable was 83.11. The lowest was 60.25. And the median was 72.52.
FRA:OM2's Days Payable is ranked better than 58.01% of 793
companies
in the Medical Devices & Instruments industry
Industry Median: 68.47
vs FRA:OM2: 83.11
Orthofix Medical's Days Payable
increased
from Jun. 2025 (66.94) to Jun. 2026 (87.95).
It may suggest that Orthofix Medicaldelayed paying its suppliers.
The historical data trend for Orthofix Medical's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:OM2 vs VMD, VREX, KIDS: Days Payable Comparison
For the Medical Devices subindustry, Orthofix Medical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orthofix Medical Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Orthofix Medical's Days Payable distribution charts can be found below:
* The bar in red indicates where Orthofix Medical's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Orthofix Medical's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orthofix Medical (FRA:OM2) has a Days Payable of 87.95 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Orthofix Medical and its competitors. This is 21% above median its historical median of 72.52. Over the past decade, Orthofix Medical's Days Payable has ranged from 60.25 to 83.11. According to the industry distribution chart, Orthofix Medical ranks #333 out of 793 companies in the Medical Devices & Instruments industry, placing it in the top 42%.
Is Orthofix Medical's Days Payable too high?
Orthofix Medical's current Days Payable of 87.95 is 21% above median its 10-year median of 72.52. Over the past 10 years, this metric has ranged from a low of 60.25 to a high of 83.11. The Medical Devices & Instruments industry median Days Payable is 68.47. Orthofix Medical's value of 87.95 is 28.5% above this industry median. Based on the distribution chart, Orthofix Medical ranks #333 out of 793 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Orthofix Medical has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Orthofix Medical's Days Payable compare to VMD and VREX?
According to the Medical Devices & Instruments industry distribution chart, Orthofix Medical ranks #333 out of 793 companies for Days Payable. This puts Orthofix Medical in the upper half of its industry. The industry median Days Payable is 68.47. Orthofix Medical's value of 87.95 is 28.5% above this benchmark. Historically, Orthofix Medical's own Days Payable has ranged from 60.25 to 83.11 over the past decade. While the company's 10-year median is 72.52 vs. the industry median of 68.47, Orthofix Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.47, based on 793 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orthofix Medical's current Days Payable of 87.95 is 28.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Orthofix Medical and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orthofix Medical's current Days Payable is 87.95, which is 21% above median its own 10-year median of 72.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orthofix Medical stock overvalued right now?
Based on GuruFocus' analysis, Orthofix Medical (FRA:OM2) is currently considered Modestly Undervalued. The stock's GF Value™ is €12.11, compared to a current price of €8.70 — trading 28.2% below its estimated fair value. The current Days Payable is 87.95, which is 21% above median its 10-year median of 72.52 and 28.5% above the Medical Devices & Instruments industry median of 68.47. Orthofix Medical's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Orthofix Medical (FRA:OM2), the current Days Payable is 87.95 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Orthofix Medical (FRA:OM2) Overvalued in 2026?
Based on GuruFocus' analysis, Orthofix Medical stock appears to be undervalued.
The current stock price of €8.70 is trading 28.2% below its estimated GF Value™ of €12.11.
GuruFocus considers Orthofix Medical to be Modestly Undervalued.
Key valuation signals for FRA:OM2:
Days Payable: 87.95 (21% above median its 10-year median of 72.52)
GF Value™: €12.11 vs. price of €8.70 (28.2% below fair value)
Industry Position: 28.5% above the Medical Devices & Instruments median (#333 of 793)
No single metric tells the full story. See the FRA:OM2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.
60GF Score
Get the complete analysis for FRA:OM2
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:OM2 has been successfully added to your 
